N/A
N=278
Transoral Robotic Surgery for rECurrent Tumours of the Upper Aerodigestive Tract
Recurrent Head and Neck Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04673929 ↗Enrolled (actual)
278
Serious AEs
—
Results posted
Jan 2025
Primary outcome: Primary: Disease-free Survival at 2 Years — 111 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Royal Marsden NHS Foundation Trust
- Primary completion
- Oct 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Disease-free Survival at 2 Years |
111 | — |
| PRIMARY Disease-specific Survival at 2 Years |
219 | — |
| SECONDARY Overall Survival at 2 Years |
192 | — |
| SECONDARY Rate of Gastrostomy Use at 1 Year |
109 | — |
| SECONDARY Rate of Tracheostomy Use at 1 Year |
105 | — |
Summary
transoral Robotic surgery for rECurrent tumours of the Upper aerodigestive Tract
Eligibility Criteria
Inclusion Criteria
- Aged over 18
- Previous Head & Neck Cancer treated with radiotherapy
- Undergoing Transoral Robotic Surgery as part of their management for recurrent disease
- Surgery performed on or before July 31st 2018.
Exclusion Criteria
- Transoral Robotic Surgery used in a diagnostic setting only
- Nasopharyngeal and thyroid cancers
Data sourced from ClinicalTrials.gov (NCT04673929). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.